NSU researchers uncover genetic marker, predictor of early relapse in pediatric ALL

Researchers recently discovered that by testing the level of NER (nucleotide excision repair) gene expression, pediatric oncologists can determine the likelihood of early relapse (less than three years) in their acute lymphoblastic leukemia (ALL) patients. This

Go to Source

(Visited 1 times, 1 visits today)

Site Footer

Sliding Sidebar